All News
FDA expands Pluvicto’s metastatic castration-resistant prostate cancer indication
On March 28, 2025, the Food and Drug Administration expanded the indication for lutetium Lu 177 vipivotide tetraxetan (Pluvicto, Novartis Pharmaceuticals Corporation). Learn more.
Read MoreCocoa Extract Shows No Effect on AMD Occurrence
(MedPage Today) -- Cocoa extract supplementation among older adults had no effect overall on the occurrence of age-related macular degeneration (AMD), but there was a possible time-dependent benefit
Read MoreUtah becomes first US state to ban fluoride in public drinking water
Lawmakers say consuming teeth-strengthening mineral should be ‘individual choice’ as dentists oppose moveUtah has become the first US state to ban fluoride in public drinking water, despite widesp
Read More‘What the hell is this stuff?’: French people on the culture shock of flossing
While preventative care has not traditionally been a priority in France, US dentistry is ‘very focused’ on itThere are many established, regularly parodied cultural differences between France and
Read MoreMedPod Today: Hospital Hoarded Corpses; Washington Rundown; Match Day Trends
(MedPage Today) -- The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody.
Read MoreUtah becomes the first state to ban fluoride in public drinking water
Utah has become the first state to ban fluoride in public drinking water, despite widespread opposition from dentists and national health organizations.
Read MoreTraining Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories
To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an a
Read MoreSTAT+: Pharmalittle: We’re reading about FDA losing key personnel, a ‘colossal’ Pfizer tax dodge, and more
Both deputy directors at the key FDA center that oversees regulation of cancer drugs plan on leaving the agency
Read MoreC3TI Areas of Interest
C3TI's areas of interest span drug development programs, therapeutic areas, and disciplines. Learn more.
Read MoreFDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis
The FDA granted marketing authorization of the first diagnostic test for chlamydia, gonorrhea and trichomoniasis that can be purchased without a prescription and performed entirely at home.
Read More